Nuvo Pharmaceuticals Inc
TSX:MRV
Nuvo Pharmaceuticals Inc
TSX:MRV
Price:
29
CAD
-3.33%
Market Closed
Market Cap:
CA$212.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
CA |
|
S
|
Sharkninja Inc
NYSE:SN
|
US |
|
B
|
BlackRock Inc
F:BLQA
|
US |
|
Super Group Ltd
F:S8G1
|
ZA |
|
Biogen Inc
NASDAQ:BIIB
|
US |
|
A
|
Abbvie Inc
F:4AB
|
US |
|
O
|
Omni Lite Industries Canada Inc
OTC:OLNCF
|
US |
|
H
|
Hudbay Minerals Inc
F:OCKA
|
CA |
|
B
|
Bank of Nova Scotia
SWB:BKN
|
CA |
|
A
|
Allegheny Technologies Inc
XBER:ATD
|
US |
|
A
|
ASML Holding NV
DUS:ASME
|
NL |
|
Wolters Kluwer NV
OTC:WOLTF
|
NL |
|
A
|
AES Corp
F:AES
|
US |
|
F
|
Ford Motor Co
XMUN:FMC1
|
US |
|
T
|
Titan International Inc
F:TZ4
|
US |
|
F
|
Farmer Bros Co
SWB:FB1
|
US |
|
M
|
MSCI Inc
F:3HM
|
US |
|
S
|
Singapore Telecommunications Ltd
F:SIT4
|
SG |
|
B
|
Biogen Inc
DUS:IDP
|
US |
|
D
|
Duke Energy Corp
SWB:D2MN
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MRV's stock price target?
Not Available
MRV does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Nuvo Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 8 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 2 years is 5%.
What is the Operating Income forecast for Nuvo Pharmaceuticals Inc?
Projected CAGR
-26%
-26%
The compound annual growth rate for Operating Income over the next 4 years is -26%.
